Cited by 1014-3-3 protein interactionsPlant Molecular Biology ResearchLight effects on plants

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Mechanistic Insights into the Function of 14-3-3 Proteins as Negative Regulators of Brassinosteroid Signaling in Arabidopsis

Open access

Published version of a preprint

Abstract

Brassinosteroids (BRs) are vital plant steroid hormones sensed at the cell surface by a membrane signaling complex comprising the receptor kinase BRI1 and a SERK family co-receptor kinase. Activation of this complex lead to dissociation of the inhibitor protein BKI1 from the receptor and to differential phosphorylation of BZR1/BES1 transcription factors by the glycogen synthase kinase 3 protein BIN2. Many phosphoproteins of the BR signaling pathway, including BRI1, SERKs, BKI1 and BZR1/BES1 can associate with 14-3-3 proteins. In this study, we use quantitative ligand binding assays to define the minimal 14-3-3 binding sites in the N-terminal lobe of the BRI1 kinase domain, in BKI1, and in BZR1 from Arabidopsis thaliana. All three motifs require to be phosphorylated to specifically bind 14-3-3s with mid- to low-micromolar affinity. BR signaling components display minimal isoform preference within the 14-3-3 non-ε subgroup. 14-3-3λ and 14-3-3 ω isoform complex crystal structures reveal that BKI1 and BZR1 bind as canonical type II 14-3-3 linear motifs. Disruption of key amino acids in the phosphopeptide binding site through mutation impairs the interaction of 14-3-3λ with all three linear motifs. Notably, quadruple loss-of-function mutants from the non-ε group exhibit gain-of-function BR signaling phenotypes, suggesting a role for 14-3-3 proteins as overall negative regulators of the BR pathway. Collectively, our work provides further mechanistic and genetic evidence for the regulatory role of 14-3-3 proteins at various stages of the BR signaling cascade.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/pcp/pcae056

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Short linear motifs in BRI1, BKI1 and BZR1 represent 14-3-3 binding sites. (A) In vitro transphosphorylation assay of BRI1 versus BSK1, with an autoradiograph shown on top and a Coomassie-stained SDS-PAGE gel shown below. A maltose-binding protein (MBP) fusion protein of the wild-type BRI1 cytoplasmic domain (residues 814–1196) can efficiently trans-phosphorylate a BSK1 fragment covering residues 55–512. BSK1 phosphorylation by BRI1 mainly involves BSK1 Ser230, as previously shown (Tang et al. 2011). (B) Isothermal titration calorimetry of 14-3-3κ versus a phosphorylated short linear motif located in the N-lobe of the BRI1 kinase domain (pBRI1869−874, continuous line). Shown are integrated heat peaks (upper panel) versus time and fitted binding isotherms versus molar ratio of peptide ligand (lower panel). No binding was detected for the unphosphorylated peptide (dotted line; n.d. no detectable binding). Table summaries for dissociation constants (KD) and binding stoichiometries (N) are shown (±fitting error). (C) Location of the 14-3-3 binding motif in the BRI1 kinase domain structure. Shown is a ribbon diagram of the N-lobe of the cytoplasmic kinase domain of BRI1 (in blue, PDB-ID 5lpb, residues 869–934) (Bojar et al. 2014), and the identified 14-3-3 binding motif (in yellow, residues 869–874) harboring phosphothreonine 872 (in bonds representation). (D) Table summaries of all ITC experiments performed with the 14-3-3κ isoform. Shown are dissociation constants (KD), binding enthalpy (ΔH) and entropy (ΔS). All binding stoichiometries were 2:2 with N ∼ 1. Experiments were repeated at least twice. (E) ITC experiments performed for 14-3-3κ versus the short linear motif in BKI1 (residues 265–272), plotted as in (B). (F) ITC experiments for 14-3-3κ versus the short (residues 169–175, continuous line) and extended (residues 169–184, dashed line) linear motifs in BZR1. No binding was observed for the unphosphorylated peptide (dotted line). (G) Relative positions of the 14-3-3 binding site (in yellow), the BIN2 interacting motif (in magenta) and the bzr1-D missense mutation (Pro234→Leu) (Wang et al. 2002) mapped onto a BZR1 AlphaFold (Jumper et al. 2021) model (https://search.foldseek.com with ID Q8S307). The experimental BZR1 DNA binding motif–DNA complex structure (PDB-ID 5zd4) (Nosaki et al. 2018) is shown as a structural superposition (blue ribbon diagram).
Fig. 1 Short linear motifs in BRI1, BKI1 and BZR1 represent 14-3-3 binding sites. (A) In vitro transphosphorylation assay of BRI1 versus BSK1, with an autoradiograph shown on top and a Coomassie-stained SDS-PAGE gel shown below. A maltose-binding protein (MBP) fusion protein of the wild-type BRI1 cytoplasmic domain (residues 814–1196) can efficiently trans-phosphorylate a BSK1 fragment covering residues 55–512. BSK1 phosphorylation by BRI1 mainly involves BSK1 Ser230, as previously shown (Tang et al. 2011). (B) Isothermal titration calorimetry of 14-3-3κ versus a phosphorylated short linear motif located in the N-lobe of the BRI1 kinase domain (pBRI1869−874, continuous line). Shown are integrated heat peaks (upper panel) versus time and fitted binding isotherms versus molar ratio of peptide ligand (lower panel). No binding was detected for the unphosphorylated peptide (dotted line; n.d. no detectable binding). Table summaries for dissociation constants (KD) and binding stoichiometries (N) are shown (±fitting error). (C) Location of the 14-3-3 binding motif in the BRI1 kinase domain structure. Shown is a ribbon diagram of the N-lobe of the cytoplasmic kinase domain of BRI1 (in blue, PDB-ID 5lpb, residues 869–934) (Bojar et al. 2014), and the identified 14-3-3 binding motif (in yellow, residues 869–874) harboring phosphothreonine 872 (in bonds representation). (D) Table summaries of all ITC experiments performed with the 14-3-3κ isoform. Shown are dissociation constants (KD), binding enthalpy (ΔH) and entropy (ΔS). All binding stoichiometries were 2:2 with N ∼ 1. Experiments were repeated at least twice. (E) ITC experiments performed for 14-3-3κ versus the short linear motif in BKI1 (residues 265–272), plotted as in (B). (F) ITC experiments for 14-3-3κ versus the short (residues 169–175, continuous line) and extended (residues 169–184, dashed line) linear motifs in BZR1. No binding was observed for the unphosphorylated peptide (dotted line). (G) Relative positions of the 14-3-3 binding site (in yellow), the BIN2 interacting motif (in magenta) and the bzr1-D missense mutation (Pro234→Leu) (Wang et al. 2002) mapped onto a BZR1 AlphaFold (Jumper et al. 2021) model (https://search.foldseek.com with ID Q8S307). The experimental BZR1 DNA binding motif–DNA complex structure (PDB-ID 5zd4) (Nosaki et al. 2018) is shown as a structural superposition (blue ribbon diagram).CC BY · PubMed Central
Fig. 2 BR signaling components show no 14-3-3 isoform preference. (A) Phylogenetic tree of the 13 14-3-3 isoforms annotated in the Arabidopsis genome. The κ, λ and ω isoforms from the non-ε group used for biochemical and crystallographic experiments are highlighted in bold face. A dotted line separates the ε from the non-ε group. The tree was calculated with phyml (Guindon et al. 2010) from a multiple protein sequence alignment of all At14-3-3 isforms generated with MUSCLE (Edgar 2004) and plotted with the program NjPlot (Perrière and Thioulouse 1996). (B) Isothermal titration calorimetry of 14-3-3κ (continuous line), 14-3-3λ (dotted line) and 14-3-3 ω (blue line) versus the BKI1 minimal binding motif (residues 265–272). Shown are integrated heat peaks (upper panel) versus time and fitted binding isotherms versus molar ratio of peptide ligand (lower panel). Table summaries for dissociation constants (KD) and binding stoichiometries (N) are shown (±fitting error). (C) Binding of 14-3-3κ, 14-3-3λ and 14-3-3 ω to the minimal motif in BZR1 (residues 169–175, plotted as in (B)). (D) Grating coupled interferometry (GCI) binding kinetics of 14-3-3 ω versus BZR169−175. Shown are sensorgrams with raw data in red and their respective fits in black. Binding kinetics were analyzed by a 1-to-1 (2:2) binding model. Table summaries of kinetic parameters are shown alongside (ka, association rate constant; kd, dissociation rate constant; KD, dissociation constant).
Fig. 2 BR signaling components show no 14-3-3 isoform preference. (A) Phylogenetic tree of the 13 14-3-3 isoforms annotated in the Arabidopsis genome. The κ, λ and ω isoforms from the non-ε group used for biochemical and crystallographic experiments are highlighted in bold face. A dotted line separates the ε from the non-ε group. The tree was calculated with phyml (Guindon et al. 2010) from a multiple protein sequence alignment of all At14-3-3 isforms generated with MUSCLE (Edgar 2004) and plotted with the program NjPlot (Perrière and Thioulouse 1996). (B) Isothermal titration calorimetry of 14-3-3κ (continuous line), 14-3-3λ (dotted line) and 14-3-3 ω (blue line) versus the BKI1 minimal binding motif (residues 265–272). Shown are integrated heat peaks (upper panel) versus time and fitted binding isotherms versus molar ratio of peptide ligand (lower panel). Table summaries for dissociation constants (KD) and binding stoichiometries (N) are shown (±fitting error). (C) Binding of 14-3-3κ, 14-3-3λ and 14-3-3 ω to the minimal motif in BZR1 (residues 169–175, plotted as in (B)). (D) Grating coupled interferometry (GCI) binding kinetics of 14-3-3 ω versus BZR169−175. Shown are sensorgrams with raw data in red and their respective fits in black. Binding kinetics were analyzed by a 1-to-1 (2:2) binding model. Table summaries of kinetic parameters are shown alongside (ka, association rate constant; kd, dissociation rate constant; KD, dissociation constant).CC BY · PubMed Central
Fig. 3 Crystal structures of 14-3-3λ and 14-3-3 ω reveal type II motif binding modes for pBKI1 and pBZR1. (A) Front and rotated side view of a structural superposition of the 14-3-3λ and 14-3-3 ω homodimers, each bound to two pBZR1169−175 peptides. The two molecules (shown as Cα traces) forming the λ isoform dimer are colored in blue and orange, respectively, the 14-3-3 ω superimposes with an r.m.s.d. (root mean square deviation) of ∼1.6 Å comparing 485 corresponding Cα atoms (in gray). The pBZR1 peptides in the λ isoform are shown alongside (in bonds representation). (B) Size-exclusion chromatography coupled to right-angle light scattering (SEC-RALS) raw scattering trace of the apo 14-3-3 ω isoform (in green) and including the derived molecular masses (light green) of the homodimer. Table summaries report the observed molecular weight (MW), column retention volume (RV) and the dispersity (Mw/Mn). The calculated theoretical molecular weight for At14-3-3 ω is ∼58.3 kDa. (C) View of the 14-3-3 ω dimer interface (blue and orange ribbon diagrams) containing the previously reported Ser62 (in bonds representation), phosphorylation of which controls dimer-to-monomer transitions in Arabidopsis (Denison et al. 2014). Gray lines indicate potential steric clashes of the phosphorylated amino acid side chain with the α1-α2 loop in each protomer. (D) Structure of the pBKI1265−272 peptide (in yellow, in bonds representation) bound to 14-3-3λ with the final (2Fo—Fc) map contoured at 1.2σ. (E) Structure of pBZR1169−175 bound to 14-3-3 ω with the final (2Fo—Fc) map contoured at 1.5σ. (F) Structural superposition of pBZR1169−175 bound to 14-3-3λ (in gray, in bonds representation) or to 14-3-3 ω (in yellow). The 14-3-3λ and 14-3-3 ω isoform dimers superimpose with a r.m.s.d. of ∼0.7 Å comparing 402 corresponding Cα atoms. (G) Structural superposition of all pBKI1265−272 peptides bound to the 10 14-3-3ω molecules in the asymmetric unit with a r.m.s.d. of ∼0.5 Å over all atoms. Shown is a molecular surface view of the 14-3-3ω ligand binding site (in gray) with the pBKI1 peptides colored from yellow to green (in bonds representation). (H) Structural superposition of the different pBZR1 peptides in the 14-3-3ω—pBZR1169−175 complex (colors as in panel G). (I) Structural superposition of the 14-3-3ω pBKI1267−272 (in yellow, in bonds representation) and the Hs14-3-3ζ–type II peptide motif complex (in purple) from a synthetic library (PDB-ID 1qja, r.m.s.d is ∼0.5 Å comparing 195 corresponding Cα atoms. (Rittinger et al. 1999). (J) The same comparison as in (I) for the pBZR1169−172 peptide.
Fig. 3 Crystal structures of 14-3-3λ and 14-3-3 ω reveal type II motif binding modes for pBKI1 and pBZR1. (A) Front and rotated side view of a structural superposition of the 14-3-3λ and 14-3-3 ω homodimers, each bound to two pBZR1169−175 peptides. The two molecules (shown as Cα traces) forming the λ isoform dimer are colored in blue and orange, respectively, the 14-3-3 ω superimposes with an r.m.s.d. (root mean square deviation) of ∼1.6 Å comparing 485 corresponding Cα atoms (in gray). The pBZR1 peptides in the λ isoform are shown alongside (in bonds representation). (B) Size-exclusion chromatography coupled to right-angle light scattering (SEC-RALS) raw scattering trace of the apo 14-3-3 ω isoform (in green) and including the derived molecular masses (light green) of the homodimer. Table summaries report the observed molecular weight (MW), column retention volume (RV) and the dispersity (Mw/Mn). The calculated theoretical molecular weight for At14-3-3 ω is ∼58.3 kDa. (C) View of the 14-3-3 ω dimer interface (blue and orange ribbon diagrams) containing the previously reported Ser62 (in bonds representation), phosphorylation of which controls dimer-to-monomer transitions in Arabidopsis (Denison et al. 2014). Gray lines indicate potential steric clashes of the phosphorylated amino acid side chain with the α1-α2 loop in each protomer. (D) Structure of the pBKI1265−272 peptide (in yellow, in bonds representation) bound to 14-3-3λ with the final (2Fo—Fc) map contoured at 1.2σ. (E) Structure of pBZR1169−175 bound to 14-3-3 ω with the final (2Fo—Fc) map contoured at 1.5σ. (F) Structural superposition of pBZR1169−175 bound to 14-3-3λ (in gray, in bonds representation) or to 14-3-3 ω (in yellow). The 14-3-3λ and 14-3-3 ω isoform dimers superimpose with a r.m.s.d. of ∼0.7 Å comparing 402 corresponding Cα atoms. (G) Structural superposition of all pBKI1265−272 peptides bound to the 10 14-3-3ω molecules in the asymmetric unit with a r.m.s.d. of ∼0.5 Å over all atoms. Shown is a molecular surface view of the 14-3-3ω ligand binding site (in gray) with the pBKI1 peptides colored from yellow to green (in bonds representation). (H) Structural superposition of the different pBZR1 peptides in the 14-3-3ω—pBZR1169−175 complex (colors as in panel G). (I) Structural superposition of the 14-3-3ω pBKI1267−272 (in yellow, in bonds representation) and the Hs14-3-3ζ–type II peptide motif complex (in purple) from a synthetic library (PDB-ID 1qja, r.m.s.d is ∼0.5 Å comparing 195 corresponding Cα atoms. (Rittinger et al. 1999). (J) The same comparison as in (I) for the pBZR1169−172 peptide.CC BY · PubMed Central
Fig. 4 Mutations in the 14-3-3λ ligand binding site interfere with pBKI1, pBZR1 and pBRI1 binding. (A) Close-up view of pBZR1 (in yellow, in bonds representation) and pBKI1 (in gray) in the 14-3-3 binding groove. The side chains of Arg136, Tyr137 and Asn233 are shown as ball-and-stick models, dashed lines indicate hydrogen bonds (in gray, distance cutoff 3.0 Å). (B) Isothermal titration calorimetry of the 14-3-3λ Asn233→ Ala mutant versus pBKI1265−272 (continuous line), pBZR1169−175 (dashed line) and pBRI1869−874 (continuous blue line). Shown are integrated heat peaks (upper panel) versus time and fitted binding isotherms versus molar ratio of peptide ligand (lower panel). Table summaries for dissociation constants (KD) and binding stoichiometries (N) are shown alongside (±fitting error). (C) ITC analysis of the 14-3-3λ Arg136→ Leu/Tyr137 → Phe double mutant. Labels and colors as in panel B. (D) Analytical size exclusion chromatography of the 14-3-3λR136L/Y137F mutant. A Coomassie-stained SDS-PAGE of the homodimeric peak fractions is shown below.
Fig. 4 Mutations in the 14-3-3λ ligand binding site interfere with pBKI1, pBZR1 and pBRI1 binding. (A) Close-up view of pBZR1 (in yellow, in bonds representation) and pBKI1 (in gray) in the 14-3-3 binding groove. The side chains of Arg136, Tyr137 and Asn233 are shown as ball-and-stick models, dashed lines indicate hydrogen bonds (in gray, distance cutoff 3.0 Å). (B) Isothermal titration calorimetry of the 14-3-3λ Asn233→ Ala mutant versus pBKI1265−272 (continuous line), pBZR1169−175 (dashed line) and pBRI1869−874 (continuous blue line). Shown are integrated heat peaks (upper panel) versus time and fitted binding isotherms versus molar ratio of peptide ligand (lower panel). Table summaries for dissociation constants (KD) and binding stoichiometries (N) are shown alongside (±fitting error). (C) ITC analysis of the 14-3-3λ Arg136→ Leu/Tyr137 → Phe double mutant. Labels and colors as in panel B. (D) Analytical size exclusion chromatography of the 14-3-3λR136L/Y137F mutant. A Coomassie-stained SDS-PAGE of the homodimeric peak fractions is shown below.CC BY · PubMed Central
Fig. 5 14-3-3 Knock-out mutants from the non-ε group show BR gain-of-function phenotypes. (A) Hypocotyl growth assay of dark grown seedlings in the presence and absence of the BR biosynthesis inhibitor brassinazole (BRZ). Shown are the growth phenotypes of different non-ε group 14-3-3 loss-of-function double- and quadruple-mutant combinations compared to the Col-0 wild type, the weak receptor mutant bri1-301 (Xu et al. 2008, Sun et al. 2017, Zhang et al. 2018) and the gain-of-function allele bir3–2 (Imkampe et al. 2017) (scale bar = 0.5 cm). Shown below is the quantification of the data with relative inhibition plotted together with lower and upper confidence intervals. For each sample (genotype and treated or untreated), n = 50 biologically independent hypocotyls, from five different ½MS plates, were measured. (B) Box plots of the experiment shown in A with raw data depicted as individual dots. Untreated samples are shown in black, BRZ-treated sample in blue.
Fig. 5 14-3-3 Knock-out mutants from the non-ε group show BR gain-of-function phenotypes. (A) Hypocotyl growth assay of dark grown seedlings in the presence and absence of the BR biosynthesis inhibitor brassinazole (BRZ). Shown are the growth phenotypes of different non-ε group 14-3-3 loss-of-function double- and quadruple-mutant combinations compared to the Col-0 wild type, the weak receptor mutant bri1-301 (Xu et al. 2008, Sun et al. 2017, Zhang et al. 2018) and the gain-of-function allele bir3–2 (Imkampe et al. 2017) (scale bar = 0.5 cm). Shown below is the quantification of the data with relative inhibition plotted together with lower and upper confidence intervals. For each sample (genotype and treated or untreated), n = 50 biologically independent hypocotyls, from five different ½MS plates, were measured. (B) Box plots of the experiment shown in A with raw data depicted as individual dots. Untreated samples are shown in black, BRZ-treated sample in blue.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 109

  1. Adams, 2010, PHENIX: a comprehensive Python-based system for macromolecular structure solution, Acta Crystallogr. D Biol. Crystallogr., 66, 213, 10.1107/S0907444909052925 · DOI · Paper page
  2. Afonine, 2012, Towards automated crystallographic structure refinement with phenix.refine, Acta Cryst. D, 68, 352, 10.1107/S0907444912001308 · DOI · Paper page
  3. Amorim-Silva, 2019, TTL proteins scaffold brassinosteroid signaling components at the plasma membrane to optimize signal transduction in Arabidopsis, Plant Cell, 31, 1807, 10.1105/tpc.19.00150 · DOI
  4. Asami, 2000, Characterization of brassinazole, a triazole-type brassinosteroid biosynthesis inhibitor, Plant Physiol., 123, 93, 10.1104/pp.123.1.93 · DOI
  5. Bai, 2007, Functions of OsBZR1 and 14-3-3 proteins in brassinosteroid signaling in rice, Proc. Natl. Acad. Sci. U.S.A., 104, 13839, 10.1073/pnas.0706386104 · DOI
  6. Ballone, 2018, 14-3-3: A case study in PPI modulation, Molecules, 23, 10.3390/molecules23061386 · DOI
  7. Benzinger, 2005, The crystal structure of the non-liganded 14-3-3σ protein: insights into determinants of isoform specific ligand binding and dimerization, Cell Res., 15, 219, 10.1038/sj.cr.7290290 · DOI
  8. Bieniossek, 2012, MultiBac: expanding the research toolbox for multiprotein complexes, Trends Biochem. Sci., 37, 49, 10.1016/j.tibs.2011.10.005 · DOI
  9. Bojar, 2014, Crystal structures of the phosphorylated BRI1 kinase domain and implications for brassinosteroid signal initiation, Plant J., 78, 31, 10.1111/tpj.12445 · DOI
  10. Bücherl, 2013, Visualization of BRI1 and BAK1(SERK3) membrane receptor heterooligomers during brassinosteroid signaling, Plant Physiol., 162, 1911, 10.1104/pp.113.220152 · DOI
  11. Chaiwanon, 2016, Immunophilin-like FKBP42/TWISTED DWARF1 interacts with the receptor kinase BRI1 to regulate brassinosteroid signaling in Arabidopsis, Mol. Plant, 9, 593, 10.1016/j.molp.2016.01.008 · DOI
  12. Chang, 2009, Proteomic profiling of tandem affinity purified 14-3-3 protein complexes in Arabidopsis thaliana, Proteomics, 9, 2967, 10.1002/pmic.200800445 · DOI
  13. Clouse, 1996, A brassinosteroid-insensitive mutant in arabidopsis thaliana exhibits multiple defects in growth and development, Plant Physiol., 111, 671, 10.1104/pp.111.3.671 · DOI
  14. Davis, 2007, MolProbity: all-atom contacts and structure validation for proteins and nucleic acids, Nucleic Acids Res., 35, W375, 10.1093/nar/gkm216 · DOI
  15. Denison, 2014, Phosphorylation-related modification at the dimer interface of 14-3-3ω dramatically alters monomer interaction dynamics, Arch. Biochem. Biophys., 541, 1, 10.1016/j.abb.2013.10.025 · DOI
  16. Denison, 2011, 14-3-3 proteins in plant physiology, Semin. Cell Dev. Biol., 22, 720, 10.1016/j.semcdb.2011.08.006 · DOI
  17. De Rybel, 2009, Chemical inhibition of a subset of Arabidopsis thaliana GSK3-like kinases activates brassinosteroid signaling, Chem. Biol., 16, 594, 10.1016/j.chembiol.2009.04.008 · DOI
  18. Edgar, 2004, MUSCLE: a multiple sequence alignment method with reduced time and space complexity, BMC Bioinf., 5, 10.1186/1471-2105-5-113 · DOI
  19. Ehsan, 2005, Interaction of Arabidopsis BRASSINOSTEROID-INSENSITIVE 1 receptor kinase with a homolog of mammalian TGF-beta receptor interacting protein, Plant J., 43, 251, 10.1111/j.1365-313X.2005.02448.x · DOI
  20. Emsley, 2004, Coot: model-building tools for molecular graphics, Acta Crystallogr. D Biol. Crystallogr., 60, 2126, 10.1107/S0907444904019158 · DOI · Paper page
  21. Friedrichsen, 2000, Brassinosteroid-insensitive-1 is a ubiquitously expressed leucine-rich repeat receptor serine/threonine kinase, Plant Physiol., 123, 1247, 10.1104/pp.123.4.1247 · DOI
  22. Fuglsang, 2003, The binding site for regulatory 14-3-3 protein in plant plasma membrane H+-ATPase: Involvement Of A Region Promoting Phosphorylation-Independent Interaction In Addition To The Phosphorylation-Dependent C-Terminal End *, J. Biol. Chem., 278, 42266, 10.1074/jbc.M306707200 · DOI
  23. Fu, 2000, Proteins: structure, function, and regulation, Annu. Rev. Pharmacol. Toxicol., 40, 617, 10.1146/annurev.pharmtox.40.1.617 · DOI
  24. Gampala, 2007, An essential role for 14-3-3 proteins in brassinosteroid signal transduction in Arabidopsis, Dev. Cell, 13, 177, 10.1016/j.devcel.2007.06.009 · DOI
  25. Gao, 2021, Ion homeostasis and metabolome analysis of Arabidopsis 14-3-3 quadruple mutants to salt stress, Front. Plant Sci., 12, 10.3389/fpls.2021.697324 · DOI
  26. Gao, 2021, Physiological and interactomic analysis reveals versatile functions of Arabidopsis 14-3-3 quadruple mutants in response to Fe deficiency, Sci. Rep., 11
  27. Gao, 2014, Light modulated activity of root alkaline/neutral invertase involves the interaction with 14-3-3 proteins, Plant J., 80, 785, 10.1111/tpj.12677 · DOI
  28. Goddard, 2018, UCSF ChimeraX: meeting modern challenges in visualization and analysis, Protein Sci., 27, 14, 10.1002/pro.3235 · DOI · Paper page
  29. Gökirmak, 2015, Phosphomimetic mutation of a conserved serine residue in Arabidopsis thaliana 14-3-3ω suggests a regulatory role of phosphorylation in dimerization and target interactions, Plant Physiol. Biochem., 97, 296, 10.1016/j.plaphy.2015.10.022 · DOI
  30. Gou, 2012, Genetic evidence for an indispensable role of somatic embryogenesis receptor kinases in brassinosteroid signaling, PLoS Genet., 8, 10.1371/journal.pgen.1002452 · DOI
  31. Grove, 1979, Brassinolide, a plant growth-promoting steroid isolated from Brassica napus pollen, Nature, 281, 216, 10.1038/281216a0 · DOI
  32. Guindon, 2010, New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0, Syst. Biol., 59, 307, 10.1093/sysbio/syq010 · DOI · Paper page
  33. Hashimoto, 2010, Ao38, a new cell line from eggs of the black witch moth, ascalapha odorata (lepidoptera: noctuidae), is permissive for AcMNPV infection and produces high levels of recombinant proteins, BMC Biotechnol., 10, 10.1186/1472-6750-10-50 · DOI
  34. He, 2002, The GSK3-like kinase BIN2 phosphorylates and destabilizes BZR1, a positive regulator of the brassinosteroid signaling pathway in Arabidopsis, Proc. Natl. Acad. Sci. U.S.A., 99, 10185, 10.1073/pnas.152342599 · DOI
  35. He, 2000, Perception of brassinosteroids by the extracellular domain of the receptor kinase BRI1, Science, 288, 2360, 10.1126/science.288.5475.2360 · DOI
  36. Hohmann, 2018, The SERK3 elongated allele defines a role for BIR ectodomains in brassinosteroid signalling, Nat. Plants, 4, 345, 10.1038/s41477-018-0150-9 · DOI
  37. Hohmann, 2020, Constitutive activation of leucine-rich repeat receptor kinase signaling pathways by BAK1-INTERACTING RECEPTOR-LIKE KINASE3 chimera, Plant Cell, 32, 3311, 10.1105/tpc.20.00138 · DOI
  38. Hohmann, 2018, Mechanistic basis for the activation of plant membrane receptor kinases by SERK-family coreceptors, Pnas, 115, 3488, 10.1073/pnas.1714972115 · DOI
  39. Hothorn, 2011, Structural basis of steroid hormone perception by the receptor kinase BRI1, Nature, 474, 467, 10.1038/nature10153 · DOI
  40. Hothorn, 2008, Simultaneous inference in general parametric models, Biom J., 50, 346, 10.1002/bimj.200810425 · DOI
  41. Huang, 2018, Shade-induced nuclear localization of PIF7 is regulated by phosphorylation and 14-3-3 proteins in Arabidopsis, eLife, 7, 10.7554/eLife.31636 · DOI
  42. Imkampe, 2017, The arabidopsis leucine-rich repeat receptor kinase BIR3 negatively regulates BAK1 receptor complex formation and stabilizes BAK1, Plant Cell, 29, 2285, 10.1105/tpc.17.00376 · DOI
  43. Jaillais, 2011, Tyrosine phosphorylation controls brassinosteroid receptor activation by triggering membrane release of its kinase inhibitor, Genes Dev., 25, 232, 10.1101/gad.2001911 · DOI
  44. Jiang, 2024, Molecular evolution and interaction of 14-3-3 proteins with H+-ATPases in plant abiotic stresses, J. Exp. Bot., 75, 689, 10.1093/jxb/erad414 · DOI
  45. Jiang, 2015, The intrinsically disordered protein BKI1 is essential for inhibiting BRI1 signaling in plants, Mol. Plant, 8, 1675, 10.1016/j.molp.2015.07.012 · DOI
  46. Kabsch, 1993, Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants, J. Appl. Crystallogr., 26, 795, 10.1107/S0021889893005588 · DOI
  47. Karlova, 2006, The Arabidopsis SOMATIC EMBRYOGENESIS RECEPTOR-LIKE KINASE1 protein complex includes BRASSINOSTEROID-INSENSITIVE1, Plant Cell, 18, 626, 10.1105/tpc.105.039412 · DOI
  48. Kim, 2009, Brassinosteroid signal transduction from cell-surface receptor kinases to nuclear transcription factors, Nat. Cell Biol., 11, 1254, 10.1038/ncb1970 · DOI · Paper page
  49. Kim, 2023, Mapping the signaling network of BIN2 kinase using TurboID-mediated biotin labeling and phosphoproteomics, Plant Cell, 35, 975, 10.1093/plcell/koad013 · DOI
  50. Kitsche, 2014, Testing for qualitative interaction using ratios of treatment differences, Stat. Med., 33, 1477, 10.1002/sim.6048 · DOI
  51. Konagaya, 2004, Members of 14-3-3 protein isoforms interacting with the resistance gene product N and the elicitor of Tobacco mosaic virus, J. Gen. Plant Pathol., 70, 221, 10.1007/s10327-003-0113-4 · DOI
  52. Latz, 2007, TPK1, a Ca2+-regulated Arabidopsis vacuole two-pore K+ channel is activated by 14-3-3 proteins, Plant J., 52, 449, 10.1111/j.1365-313X.2007.03255.x · DOI
  53. Lee, 2020, proteins contribute to leaf and root development via brassinosteroid insensitive 1 in Arabidopsis thaliana, Genes Genom., 42, 347, 10.1007/s13258-019-00909-4 · DOI
  54. Li, 1997, A putative leucine-rich repeat receptor kinase involved in brassinosteroid signal transduction, Cell, 90, 929, 10.1016/S0092-8674(00)80357-8 · DOI
  55. Li, 2023, Scaffold protein RACK1 regulates BR signaling by modulating the nuclear localization of BZR1, New Phytol., 239, 1804, 10.1111/nph.19049 · DOI
  56. Li, 2002, Regulation of brassinosteroid signaling by a GSK3/SHAGGY-like kinase, Science, 295, 1299, 10.1126/science.1065769 · DOI
  57. Li, 2001, BIN2, a new brassinosteroid-insensitive locus in Arabidopsis, Plant Physiol., 127, 14, 10.1104/pp.127.1.14 · DOI
  58. Li, 2002, BAK1, an Arabidopsis LRR receptor-like protein kinase, interacts with BRI1 and modulates brassinosteroid signaling, Cell, 110, 213, 10.1016/S0092-8674(02)00812-7 · DOI
  59. Lozano-Durán, 2014, The bacterial effector HopM1 suppresses PAMP-triggered oxidative burst and stomatal immunity, New Phytol., 202, 259, 10.1111/nph.12651 · DOI
  60. McCoy, 2007, Phaser crystallographic software, J. Appl. Crystallogr., 40, 658, 10.1107/S0021889807021206 · DOI · Paper page
  61. Modi, 2020, Two negatively charged invariant residues influence ligand binding and conformational dynamics of 14-3-3ζ, FEBS Lett., 594, 878, 10.1002/1873-3468.13662 · DOI
  62. Mora-García, 2004, Nuclear protein phosphatases with Kelch-repeat domains modulate the response to brassinosteroids in Arabidopsis, Genes Dev., 18, 448, 10.1101/gad.1174204 · DOI
  63. Muslin, 1996, Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine, Cell, 84, 889, 10.1016/S0092-8674(00)81067-3 · DOI
  64. Nam, 2002, BRI1/BAK1, a receptor kinase pair mediating brassinosteroid signaling, Cell, 110, 203, 10.1016/S0092-8674(02)00814-0 · DOI · Paper page
  65. Nosaki, 2018, Structural basis for brassinosteroid response by BIL1/BZR1, Nat. Plants, 4, 771, 10.1038/s41477-018-0255-1 · DOI
  66. Novikova, 2022, Meet your MAKR: the membrane-associated kinase regulator protein family in the regulation of plant development, FEBS J., 289, 6172, 10.1111/febs.16132 · DOI
  67. Oh, 2000, Recombinant brassinosteroid insensitive 1 receptor-like kinase autophosphorylates on serine and threonine residues and phosphorylates a conserved peptide motif in vitro, Plant Physiol., 124, 751, 10.1104/pp.124.2.751 · DOI
  68. Oh, 2009, Tyrosine phosphorylation of the BRI1 receptor kinase emerges as a component of brassinosteroid signaling in Arabidopsis, Proc. Natl. Acad. Sci. U.S.A., 106, 658, 10.1073/pnas.0810249106 · DOI
  69. Ottmann, 2007, Structure of a 14-3-3 coordinated hexamer of the plant plasma membrane H+ -ATPase by combining X-ray crystallography and electron cryomicroscopy, Mol. Cell, 25, 427, 10.1016/j.molcel.2006.12.017 · DOI · Paper page
  70. Peng, 2010, A direct docking mechanism for a plant GSK3-like kinase to phosphorylate its substrates, J. Biol. Chem., 285, 24646, 10.1074/jbc.M110.142547 · DOI
  71. Perrière, 1996, On-line tools for sequence retrieval and multivariate statistics in molecular biology, Comput. Appl. Biosci., 12, 63
  72. Prado, 2019, Oscillating aquaporin phosphorylation and 14-3-3 proteins mediate the circadian regulation of leaf hydraulics, Plant Cell, 31, 417, 10.1105/tpc.18.00804 · DOI
  73. Puntervoll, 2003, ELM server: a new resource for investigating short functional sites in modular eukaryotic proteins, Nucleic Acids Res., 31, 3625, 10.1093/nar/gkg545 · DOI
  74. Reuter, 2021, Light-triggered and phosphorylation-dependent 14-3-3 association with NON-PHOTOTROPIC HYPOCOTYL 3 is required for hypocotyl phototropism, Nat. Commun., 12, 10.1038/s41467-021-26332-6 · DOI · Paper page
  75. Rienties, 2005, The arabidopsis SERK1 protein interacts with the AAA-ATPase AtCDC48, the 14-3-3 protein GF14lambda and the PP2C phosphatase KAPP, Planta, 221, 394, 10.1007/s00425-004-1447-7 · DOI
  76. Rittinger, 1999, Structural analysis of 14-3-3 phosphopeptide complexes identifies a dual role for the nuclear export signal of 14-3-3 in ligand binding, Mol. Cell, 4, 153, 10.1016/S1097-2765(00)80363-9 · DOI
  77. Ryu, 2010, Phosphorylation dependent nucleocytoplasmic shuttling of BES1 is a key regulatory event in brassinosteroid signaling, Mol. Cells, 29, 283, 10.1007/s10059-010-0035-x · DOI
  78. Ryu, 2007, Nucleocytoplasmic shuttling of BZR1 mediated by phosphorylation is essential in Arabidopsis brassinosteroid signaling, Plant Cell, 19, 2749, 10.1105/tpc.107.053728 · DOI
  79. Santiago, 2013, Molecular mechanism for plant steroid receptor activation by somatic embryogenesis co-receptor kinases, Science, 341, 889, 10.1126/science.1242468 · DOI · Paper page
  80. Schindelin, 2012, Fiji: an open-source platform for biological-image analysis, Nat. Methods, 9, 676, 10.1038/nmeth.2019 · DOI · Paper page
  81. Schmidt, 1997, A leucine-rich repeat containing receptor-like kinase marks somatic plant cells competent to form embryos, Development, 124, 2049, 10.1242/dev.124.10.2049 · DOI
  82. She, 2011, Structural insight into brassinosteroid perception by BRI1, Nature, 474, 472, 10.1038/nature10178 · DOI
  83. Sirichandra, 2010, The Arabidopsis ABA-activated kinase OST1 phosphorylates the bZIP transcription factor ABF3 and creates a 14-3-3 binding site involved in its turnover, PLoS One, 5, 10.1371/journal.pone.0013935 · DOI
  84. Stanislas, 2009, Quantitative proteomics reveals a dynamic association of proteins to detergent-resistant membranes upon elicitor signaling in Tobacco *, Mol. Cell. Proteomics, 8, 2186, 10.1074/mcp.M900090-MCP200 · DOI
  85. Sullivan, 2009, Interaction specificity of Arabidopsis 14-3-3 proteins with phototropin receptor kinases, Febs. Lett., 583, 2187, 10.1016/j.febslet.2009.06.011 · DOI
  86. Sun, 2017, Scanning for new BRI1 mutations via TILLING analysis, Plant Physiol., 174, 1881, 10.1104/pp.17.00118 · DOI
  87. Tang, 2011, PP2A activates brassinosteroid-responsive gene expression and plant growth by dephosphorylating BZR1, Nat. Cell Biol., 13, 124, 10.1038/ncb2151 · DOI
  88. Taoka, 2011, 14-3-3 proteins act as intracellular receptors for rice Hd3a florigen, Nature, 476, 332, 10.1038/nature10272 · DOI
  89. Tseng, 2012, The role of a 14-3-3 protein in stomatal opening mediated by PHOT2 in Arabidopsis, Plant Cell, 24, 1114, 10.1105/tpc.111.092130 · DOI
  90. van Kleeff, 2014, Higher order Arabidopsis 14-3-3 mutants show 14-3-3 involvement in primary root growth both under control and abiotic stress conditions, J. Exp. Bot., 65, 5877, 10.1093/jxb/eru338 · DOI
  91. Vert, 2006, Downstream nuclear events in brassinosteroid signalling, Nature, 441, 96, 10.1038/nature04681 · DOI
  92. Waksman, 2023, Phototropin phosphorylation of ROOT PHOTOTROPISM 2 and its role in mediating phototropism, leaf positioning, and chloroplast accumulation movement in Arabidopsis, Plant J., 114, 390, 10.1111/tpj.16144 · DOI
  93. Wang, 2006, Brassinosteroids regulate dissociation of BKI1, a negative regulator of BRI1 signaling, from the plasma membrane, Science, 313, 1118, 10.1126/science.1127593 · DOI
  94. Wang, 2005, Identification and functional analysis of in vivo phosphorylation sites of the Arabidopsis BRASSINOSTEROID-INSENSITIVE1 receptor kinase, Plant Cell, 17, 1685, 10.1105/tpc.105.031393 · DOI
  95. Wang, 2014, Structural insights into the negative regulation of BRI1 signaling by BRI1-interacting protein BKI1, Cell Res., 24, 1328, 10.1038/cr.2014.132 · DOI
  96. Wang, 2008, Sequential transphosphorylation of the BRI1/BAK1 receptor kinase complex impacts early events in brassinosteroid signaling, Dev. Cell, 15, 220, 10.1016/j.devcel.2008.06.011 · DOI
  97. Wang, 2002, Nuclear-localized BZR1 mediates brassinosteroid-induced growth and feedback suppression of brassinosteroid biosynthesis, Dev. Cell, 2, 505, 10.1016/S1534-5807(02)00153-3 · DOI
  98. Wang, 2001, BRI1 is a critical component of a plasma-membrane receptor for plant steroids, Nature, 410, 380, 10.1038/35066597 · DOI · Paper page
  99. Wang, 2013, Identification of BZR1-interacting proteins as potential components of the brassinosteroid signaling pathway in arabidopsis through tandem affinity purification, Mol. Cell. Proteomics, 12, 3653, 10.1074/mcp.M113.029256 · DOI
  100. Wang, 2011, Dual role of BKI1 and 14-3-3 s in brassinosteroid signaling to link receptor with transcription factors, Dev. Cell, 21, 825, 10.1016/j.devcel.2011.08.018 · DOI
  101. Xu, 2008, Is kinase activity essential for biological functions of BRI1?, Cell Res., 18, 472, 10.1038/cr.2008.36 · DOI
  102. Xu, 2012, TFT6 and TFT7, two different members of tomato 14-3-3 gene family, play distinct roles in plant adaption to low phosphorus stress, Plant Cell Environ., 35, 1393, 10.1111/j.1365-3040.2012.02497.x · DOI
  103. Yaffe, 1997, The structural basis for 14-3-3: phosphopeptide binding specificity, Cell, 91, 961, 10.1016/S0092-8674(00)80487-0 · DOI
  104. Yang, 2006, Structural basis for protein–protein interactions in the 14-3-3 protein family, Proc. Natl. Acad. Sci., 103, 17237, 10.1073/pnas.0605779103 · DOI
  105. Yang, 2019, Calcium-activated 14-3-3 proteins as a molecular switch in salt stress tolerance, Nat. Commun., 10
  106. Yin, 2002, BES1 accumulates in the nucleus in response to brassinosteroids to regulate gene expression and promote stem elongation, Cell, 109, 181, 10.1016/S0092-8674(02)00721-3 · DOI
  107. Yu, 2023, Auxin promotes hypocotyl elongation by enhancing BZR1 nuclear accumulation in Arabidopsis, Sci. Adv., 9, 10.1126/sciadv.ade2493 · DOI
  108. Zhang, 2018, A temperature-sensitive misfolded bri1-301 receptor requires its kinase activity to promote growth1 [OPEN], Plant Physiol., 178, 1704, 10.1104/pp.18.00452 · DOI
  109. Zhao, 2002, Two putative BIN2 substrates are nuclear components of brassinosteroid signaling, Plant Physiol., 130, 1221, 10.1104/pp.102.010918 · DOI

Metadata

Authors
Obergfell, E., Hohmann, U., Moretti, A., Chen, H., & Hothorn, M.
Affiliations
University of Geneva (CH)
Corresponding author
Hothorn, Michael
Venue
Plant And Cell Physiology
Published
2024-05-23
Volume
65
Issue
10
Pages
1674-1688
ISSN
  • 0032-0781 (ISSN-L)
  • 1471-9053
OpenAlex
W4398782129
Cited by
10
References
1
Citations by year
2026: 2 · 2025: 6 · 2024: 2
FWCI
1.36
Type
journal article
Language
en
Open access
Locations
  • Plant and Cell Physiology (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
  • DORA PSI (Paul Scherrer Institute) (submittedVersion, cc-by)
Funders
  • Howard Hughes Medical Institute (55008733)
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (310030_205201)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › 14-3-3 protein interactions
  • Life Sciences › Agricultural and Biological Sciences › Plant Science › Plant Molecular Biology Research
  • Life Sciences › Agricultural and Biological Sciences › Plant Science › Light effects on plants
Keywords
14-3-3 proteins, brassinosteroid signaling, BRI1, BZR1, BES1, BIN2, 14-3-3 binding motif, phosphopeptide binding, negative regulation, ligand binding assay, crystal structure, Arabidopsis thaliana, receptor kinase signaling
MeSH terms
Binding Sites, DNA-Binding Proteins, Phosphorylation, Protein Binding, Protein Kinases, Signal Transduction, Arabidopsis, Arabidopsis Proteins, 14-3-3 Proteins, Brassinosteroids

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review